These communication tools are available to share and print in helping prevent the spread of COVID‑19. Feel free to display and/or distribute on social media to communicate key information to the public about COVID‑19. On Twitter please tag @Amref_Worldwide when posting graphics from our COVID‑...19 social media toolkit.
more
Clinical Medicine
JCI Insight. 2017;2(7):e91963.
Лучевые исследования в диагностике Covid-19 и алгоритмы действий
(ensuring COVID readiness of radiation diagnostics departments)
Ein kompakter Ratgeber
23. aktualisierte Auflage
Bei der Bewältigung der Alzheimer-Krankheit und anderer Formen der Demenz müssen viele Personen zusammenwirken: der Patient selbst, seine Angehörigen, Freunde und Bekannte, der Hausarzt und spezialisierte Ärzte, oft auch die Mitarbeiter von Be...ratungsstellen, Tagesstätten und Pflegeeinrichtungen. Sie alle brauchen Informationen über die Krankheit. Das Wichtigste über Demenzerkrankungen zu vermitteln, ist das Ziel des vorliegenden kompakten Ratgebers, den Ihnen die Deutsche Alzheimer Gesellschaft gerne überreicht.
more
This is an update (third edition) of the BACPR Standards & Core Components and represents current evidence-based best practice and a pragmatic overview of the structure and function of Cardiovascular Prevention and Rehabilitation Programmes (CPRPs) in the UK. The previously described seven standards... have now been reduced to six but without sacrificing any of the key elements and with a greater emphasis placed on measurable clinical outcomes, audit and certification. Similarly, the second edition provided an overview of seven core components felt to be essential for the delivery of quality prevention and rehabilitation, and this too has been reduced to six. The interplay between cardio-protective therapies and medical risk factors is almost impossible to disentangle for the vast majority of patients and even if specific drug therapies are deployed exclusively for risk factor modulation, the indirect effect will also be cardio-protective. Thus, these have been combined into a single core component – medical risk management.
more
Nature Medicine, https://doi.org/10.1038/s41591-021-01283-z
Guideline
SAJHIVMED DECEMBER 2013, Vol. 14, No. 4
The 2021 Financing for Sustainable Development Report responds to the request made by Member States to review the impact of the COVID-19 pandemic on nancing for sustainable development, and to propose recommendations to rebuild better. The report underlines the need for policy actions to ensure e e...ctive support until the recovery is rmly underway. Its thematic chapter discusses the systemic and interlinked nature of risk in a tightly intertwined world, and the importance of providing nancing for risk reduction and resilience and nancing that is risk-informed and resilient. With the collaboration of more than 60 agencies of the United Nations system and partner international organizations, the report provides much needed guidance to Member States to take action towards a more resilient future.
more
Guidelines for national programmes and other stakeholders
Annexes for webposting and CD-Rom distribution with the policy guidelines
Guidelines for national programmes and other stakeholders
世界卫生组织 结核菌/艾滋病病毒双 重感染防治政策指南
——适用于国家规划 和利益攸关方
This guide provides a systematic, practical approach to support primary care and other healthcare professionals to improve the care of peopel over the age of 18 years with difficult to manage asthma.
Infection preventions
Hygiene
Situation Analaysis and Needs Assessment
An Indicator-based Approach - This manual presents an indicator-based approach for rapidly assessing pharmaceutical management systems and programs. The manual contains a set of 46 indicators of performance, grouped under eight topics of pharmaceutical management, with each topic being covered by a ...subset of indicators. Thirty-four of the indicators are quantitative, that is, expressed as numbers. Twelve are qualitative, in that they describe the presence or absence of a policy or management system, and in some cases, the degree of implementation.
more
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002514 March 1, 2018
Проблема раннего детского аутизма в настоящее время является одной из наиболее актуальных,
что обусловлено, прежде всего, огромным ростом статистических показат...лей распространенности
данного диагноза по всему миру. В статье рассматриваются клинические проявления раннего
детского аутизма, описываются основные симптомы и синдромы раннего детского аутизма, на
которые необходимо обращать внимание детским специалистам (педиатрам, неврологам) при
первичном обращении таких пациентов, а также дается обобщенная характеристика
диагностических проблем при выявлении раннего детского аутизма у детей в возрасте от 1 до
3 лет и основные дифференциально-диагностические критерии.
more